CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
research article
Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries
Authors
R. Ahmed
A.K. Al-Ali
+279 more
F.A. Al-Muhanna
A.M. Al-Rubaish
N.Y.Y. Al-Windy
M. Alkhalil
T.E. Alling
Y.A. Almubarak
A.N. Alnafie
M. Alshahrani
A.M. Alshehri
C. Anning
R.L. Anthonio
Folkert W. Asselbergs
A. Aujayeb
E.A. Badings
C. Ball
E.C.E. Bayraktar-Verver
R.M. Bell
F.J. Bermúdez Jiménes
M. Bianco
C.A. Biolé
O.V. Blagova
H. Bleijendaal
M. Bontje
W.L. Bor
S. Borgmann
M. Bos
L. Bosch
M. Broekman
F.J.F. Broeyer
S. Bruinsma
C. Bucciarelli-Ducci
R. Byrom-Goulthorp
G. Captur
M. Caputo
N.M. Cardoso
N. Charlotte
B. Cosyns
P. Dark
E.A.W. de Bruijn
J. De Sutter
J.K. de Vries
T.A.C. de Vries
K. de With
C. Degenhardt
E. Dekimpe
C.E. Delsing
P. den Boer-Penning
C.A. den Uil
S. Dolff
J. Domange
F. Dormal
H.G.R. Dorman
I.M.J. Drost
J.T. Drost
A. Dunnink
L. Eberwein
K. Elshinawy
M.E. Emans
A.G. Er
J.B. Ferreira
M.J. Forner
A. Friedrichs
L. Gabriel
R.M.M. Gevers
D.G. Gognieva
S. Grangeon
B.E. Groenemeijer
A.L. Groenendijk
B. Grüner
A. Guclu
W. Guggemos
A. Habib
N.A. Haenen
H.E. Haerkens-Arends
K. Hamilton
S. Handgraaf
F. Hanses
B. Hedayat
H. Heidbuchel
D. Heigener
E. Hellou
K. Hellwig
M. Hendriks-Van Woerden
M.T.H.M. Henkens
R.S. Hermanides
W.R.M. Hermans
J.F. Hermans-Van Ast
B.M. Hessels-Linnemeijer
S.R.B. Heymans
A.D. Hilt
K. Hosseini
M. Hower
J. Huisman
N. Isberner
T.C. Jacobs
C.E.M. Jakob
S.E. Jansen
A. Janssen
B. Jensen
L.S. Jewbali
K. Jourdan
M.T. Kearney
J.T. Kielstein
B.L.J.H. Kietselaer
C.M. Kievit
P. Kleikers
N. Knufman
M. Kochanek
M.Z.H. Kolk
A.M.H. Koning
B.A.S. Koole
M.A.C. Koole
P.Y. Kopylov
K.K. Kui
A.F.M. Kuijper
L. Kuipers-Elferink
J.M. Kwakkel-Van Erp
J. Lanznaster
N.C. Lea
I. Lemoine
E. Lensink
M. Linschoten
G.C.M. Linssen
D. Lomas
M. Maarse
R. Macías Ruiz
F.J.H. Magdelijns
M. Magro
P. Markart
F.M.A.C. Martens
S.G. Mazzilli
G.P. McCann
E. McFarlane
E.J. Meijer
M.F.L. Meijs
A.J. Melein
U. Merle
D.F. Mesitskaya
P. Messiaen
M. Milovanovic
P.S. Monraats
L. Montagna
A. Moriarty
A.J. Moss
A. Mosterd
S. Nadalin
J. Nattermann
M. Neufang
P.R. Nierop
J.A. Offerhaus
F.M.A. Paris
E. Parker
R.S. Patel
M.G. Perrelli
A.M. Persoon
C. Piepel
A. Pieterse-Rots
L. Pilgram
Y.M. Pinto
R. Pisters
H. Poorhosseini
S. Prasad
B.C. Pölkerman
A.G. Raafs
C. Raichle
D. Rauschning
J. Redón
A.C. Reidinga
S. Reinders
M.J. Reitsma
M.I.A. Ribeiro
C. Riedel
S. Rieg
D.P. Ripley
L.R. Romão
K. Rothfuss
A.H. Ruiter
C. Römmele
J. Rüddel
M.M. Rüthrich
R. Salah
E. Saneei
M. Saxena
J. Schaap
D.A.A.M. Schellings
N.T.B. Scholte
J. Schubert
A. Schut
J. Seelig
J.L. Selder
A. Shafiee
A.C. Shore
H.J. Siebelink
P.C. Smits
A.I.C. Sousa
C. Spinner
M. Stecher
S. Stieglitz
R. Strauss
N.H. Sturkenboom
M. Tajdini
J.M. Ten Berg
G.L. ten Kate
L. Tercedor Sánchez
E. Tessitore
R.J. Thomson
R.G. Tieleman
P. Timmermans
R.A. Tio
F.V.Y. Tjong
L. Tometten
J. Trauth
A. Uijl
K. van Aken
E.A. van Beek
A.J.M. van Boxem
B.C.T. van Bussel
E.M. Van Craenenbroeck
D.H. van Dalen
C.M. Van De Heyning
R.M.A. van de Wal
D.J. van de Watering
F.S. van den Brink
M. van der Graaf
P. van der Harst
D.J. van der Heijden
I.C.C. van der Horst
S.E. van der Kooi
M.M.J.M. van der Linden
A.C.J. van der Lingen
P. van der Meer
A. van der Sluis
P.M. van der Zee
J.L. van Doorn
P. van Doorn
J.W.M. van Eck
W.H. van Gilst
M.W.J. van Hessen
S.H. van Ierssel
E.P.A. van Iperen
M.J. van Kempen
H.A.M. van Kesteren
V. van Marrewijk
J.P. van Meerbeeck
C.P.M. van Nes
C.E.E. van Ofwegen-Hanekamp
A. van Poppel
M. van Smeden
H.P.A.A. van Veen
M.J.G.T. Vehreschild
L.I. Veldhuis
T. Veneman
D.O. Verschure
H. Vial
E. Vlieghe
I. Voigt
J. vom Dahl
M. von Bergwelt-Baildon
H.E. Vonkeman
P. Vreugdenhil
L. Walter
I.C.D. Westendorp
P.H.M. Westendorp
T. Westhoff
C. Weytjens
E. Wierda
K. Wille
A.M. Willems
B. Williams
S. Williams
A.M. Wils
M. Worm
P. Woudstra
K.W. Wu
R. Zaal
A.G. Zaman
L.E. Zijlstra
S.K. Zoet-Nugteren
A.G.M. Zondag
Publication date
1 January 2022
Publisher
Doi
Cite
Abstract
© The Author(s) 2021Aims Patients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital mortality. Methods and results We used data from the CAPACITY-COVID registry and LEOSS study. Multivariable Poisson regression models were fitted to assess the association between different types of pre-existing heart disease and in-hospital mortality. A total of 16 511 patients with COVID-19 were included (21.1% aged 66-75 years; 40.2% female) and 31.5% had a history of heart disease. Patients with heart disease were older, predominantly male, and often had other comorbid conditions when compared with those without. Mortality was higher in patients with cardiac disease (29.7%; n = 1545 vs. 15.9%; n = 1797). However, following multivariable adjustment, this difference was not significant [adjusted risk ratio (aRR) 1.08, 95% confidence interval (CI) 1.02-1.15; P = 0.12 (corrected for multiple testing)]. Associations with in-hospital mortality by heart disease subtypes differed considerably, with the strongest association for heart failure (aRR 1.19, 95% CI 1.10-1.30; P < 0.018) particularly for severe (New York Heart Association class III/IV) heart failure (aRR 1.41, 95% CI 1.20-1.64; P < 0.018). None of the other heart disease subtypes, including ischaemic heart disease, remained significant after multivariable adjustment. Serious cardiac complications were diagnosed in <1% of patients. Conclusion Considerable heterogeneity exists in the strength of association between heart disease subtypes and in-hospital mortality. Of all patients with heart disease, those with heart failure are at greatest risk of death when hospitalized with COVID-19. Serious cardiac complications are rare during hospitalization
Similar works
Full text
Available Versions
Hacettepe University Reserach Information System
See this paper in CORE
Go to the repository landing page
Download from data provider
e012168c-3b4a-4d20-b890-735f94...
Last time updated on 17/04/2025
Lirias
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lirias2repo.kuleuven.be:20...
Last time updated on 24/10/2022